3D-printed hierarchical scaffold for localized isoniazid/rifampin drug delivery and osteoarticular tuberculosis therapy

Acta Biomaterialia

Volumn 16, Issue 1, 2015, Pages 145-155

  Min, Zhu ^a   Kun, Li ^b   Yufang, Zhu ^a   Jianhua, Zhang ^a   Xiaojian, Ye ^b  

^a UNIVERSITY OF SHANGHAI FOR SCIENCE AND TECHNOLOGY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Localized drug release; Long term antituberculosis therapy; Mesoporous bioceramics; Multi drug delivery

Indexed keywords

BIOCERAMICS; BONE; CALCIUM PHOSPHATE; COMPUTERIZED TOMOGRAPHY; CONTROLLED DRUG DELIVERY; DEFECTS; DRUG DOSAGE; DRUG INTERACTIONS; HISTOLOGY; SCAFFOLDS; TARGETED DRUG DELIVERY; TISSUE REGENERATION;

ANTITUBERCULOSIS; COMPOSITE SCAFFOLDS; DRUG RELEASE; LOCALISED; LOCALIZED DRUG RELEASE; LONG-TERM ANTITUBERCULOSIS THERAPY; MESOPOROUS; MESOPOROUS BIOCERAMIC; MULTI-DRUG DELIVERY; SURGICAL TREATMENT;

3D PRINTERS;

BIOCERAMICS; COPOLYMER; ISONIAZID; POLY(3 HYDROXYBUTYRATE CO 3 HYDROXYHEXANOATE); RIFAMPICIN; UNCLASSIFIED DRUG; GLASS; NANOPARTICLE; POWDER; SILICON DIOXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE GROWTH; BONE MINERALIZATION; BONE REGENERATION; CALCIUM PHOSPHATE CERAMIC; CELL ADHESION; CELL PROLIFERATION; COMPOSITE MATERIAL; COMPOSITE SCAFFOLD; CONTROLLED STUDY; DEBRIDEMENT; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FUNCTION; LIVER FUNCTION; MALE; MICRO-COMPUTED TOMOGRAPHY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OSSIFICATION; POWDER; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; THREE DIMENSIONAL PRINTING; TRANSMISSION ELECTRON MICROSCOPY; TUBERCULOUS ARTHRITIS; ANIMAL; CHEMISTRY; DRUG EFFECTS; FEMUR; KIDNEY; KIDNEY FUNCTION TEST; LIVER; PATHOLOGY; POROSITY; RABBIT; RADIOGRAPHY; TEMPERATURE; TISSUE SCAFFOLD; TUBERCULOSIS, OSTEOARTICULAR;

ANIMALS; DRUG DELIVERY SYSTEMS; FEMALE; FEMUR; GLASS; HUMANS; ISONIAZID; KIDNEY; KIDNEY FUNCTION TESTS; LIVER; MALE; NANOPARTICLES; OSTEOGENESIS; POROSITY; POWDERS; PRINTING, THREE-DIMENSIONAL; RABBITS; RIFAMPIN; SILICON DIOXIDE; TEMPERATURE; TISSUE SCAFFOLDS; TUBERCULOSIS, OSTEOARTICULAR;

EID: 84930200823     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2015.01.034     Document Type: Article

References (44)

1. Davies PDO. Drug-resistant tuberculosis. J R Soc Med 2001;94:261-3.
2. Ranjita S, Loaye A, Khalil M. Present status of nanoparticle research for treatment of tuberculosis. J Pharm Pharm Sci 2011;14:100-16.
3. Blasi P, Schoubben A, Giovagnoli S, Rossi C, Ricci M. Fighting tuberculosis: old drugs, new formulations. Expert Opin Drug Deliv 2009;6:977-93.
4. Sosnik A, Carcaboso AM, Glisoni RJ, Moretton MA, Chiappetta DA. New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery. Adv Drug Deliv Rev 2010;62:547-59.
5. Mateo L, Olive A, Ruiz J, Casares EG, Melchor EG, Minguez S, et al. On bone and joint tuberculosis: two decade study of 53 cases. Ann Rheum Dis 2007;66:538.
6. Pigrau-Serrallach C, Rodriguez-Pardo D. Bone and joint tuberculosis. Eur Spine J 2013;22:556-66.
7. Garg RK, Somvanshi DS. Spinal tuberculosis: a review. J Spinal Cord Med 2011;34:440-54.
8. Jain AK, Jain S. Instrumented stabilization in spinal tuberculosis. Int Orthop 2012;36:285-92.
9. Dooley KE, Obuku EA, Durakovic N, Belitsky V, Mitnick C, Nuermberger EL. World health organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential? J Infect Dis 2013;207:1352-8.
10. Bahna P, Dvorak T, Hanna H, Yasko AW, Hachem R, Raad I. Orthopaedic metal devices coated with a novel antiseptic dye for the prevention of bacterial infections. Int J Antimicrob Agents 2007;29:593-6.
11. Sharma A, Sharma S, Khuller GK. Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis. J Antimicrob Chemother 2004;54:761-6.
12. Pandey R, Sharma A, Zahoor A, Sharma S, Khuller GK, Prasad B. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. J Antimicrob Chemother 2003;52:981-6.
13. Ohashi K, Kabasawa T, Ozeki T, Okada H. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis. J Control Release 2009;135:19-24.
14. Dutt M, Khuller GK. Sustained release of isoniazid from a single injectable dose of poly (DL-lactide-co-glycolide) microparticles as a therapeutic approach towards tuberculosis. Int J Antimicrob Agents 2001;17:115-22.
15. Batycky RP, Hanes J, Langer R, Edwards DA. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J Pharm Sci 1997;86:1464-77.
16. Mader K, Gallez B, Liu KJ, Swartz HM. Non-invasive in vivo characterization of release processes in biodegradable polymers by low-frequency electron paramagnetic resonance spectroscopy. Biomaterials 1996;17:457-61.
17. Louw GE, Warren RM, van Pittius NCG, McEvoy CRE, Van Helden PD, Victor TC. A balancing act: efflux/influx in mycobacterial drug resistance. Antimicrob Agents Chemother 2009;53:3181-9.
18. Manzano M, Vallet-Regi M. New developments in ordered mesoporous materials for drug delivery. J Mater Chem 2010;20:5593-604.
19. Saha D, Warren KE, Naskar AK. Soft-templated mesoporous carbons as potential materials for oral drug delivery. Carbon 2014;71:47-57.
20. Vallet-Regi M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed 2007;46:7548-58.
21. Shen SC, Ng WK, Chia LSO, Dong YC, Tan RBH. Applications of mesoporous materials as excipients for innovative drug delivery and formulation. Curr Pharm Des 2013;19:6270-89.
22. Zhu M, Wang HX, Liu JY, He HL, Hua XG, He QJ, et al. A mesoporous silica nanoparticulate/beta-TCP/BG composite drug delivery system for osteoarticular tuberculosis therapy. Biomaterials 2011;32:1986-95.
23. Doadrio JC, Sousa EMB, Izquierdo-Barba I, Doadrio AL, Perez-Pariente J, Vallet-Regi M. Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern. J Mater Chem 2006;16:462-6.
24. Yang PP, Gai SL, Lin J. Functionalized mesoporous silica materials for controlled drug delivery. Chem Soc Rev 2012;41:3679-98.
25. Song SW, Hidajat K, Kawi S. Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions. Langmuir 2005;21:9568-75.
26. Munoz B, Ramila A, Perez-Pariente J, Diaz I, Vallet-Regi M. MCM-41 organic modification as drug delivery rate regulator. Chem Mater 2003;15:500-3.
27. Ramila A, Munoz B, Perez-Pariente J, Vallet-Regi M. Mesoporous MCM-41 as drug host system. J Sol-Gel Sci Technol 2003;26:1199-202.
28. Vallet-Regi M. Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. Chem Eur J 2006;12:5934-43.
29. Zhu M, Shi JL, He QJ, Zhang LX, Chen F, Chen Y. An emulsification-solvent evaporation route to mesoporous bioactive glass microspheres for bisphosphonate drug delivery. J Mater Sci 2012;47:2256-63.
30. Zhu YF, Kaskel S. Comparison of the in vitro bioactivity and drug release property of mesoporous bioactive glasses (MBGs) and bioactive glasses (BGs) scaffolds. Microporous Mesoporous Mater 2009;118:176-82.
31. Yun HS, Kim SE, Hyeon YT. Design and preparation of bioactive glasses with hierarchical pore networks. Chem Commun 2007:2139-41.
32. Li X, Wang XP, Chen HR, Jiang P, Dong XP, Shi JL. Hierarchically porous bioactive glass scaffolds synthesized with a PUF and P123 cotemplated approach. Chem Mater 2007;19:4322-6.
33. Su JC, Cao LH, Yu BQ, Song SJ, Liu XW, Wang ZW, et al. Composite scaffolds of mesoporous bioactive glass and polyamide for bone repair. Int J Nanomed 2012;7:2547-55.
34. Luo YX, Wu CT, Lode A, Gelinsky M. Hierarchical mesoporous bioactive glass/alginate composite scaffolds fabricated by three-dimensional plotting for bone tissue engineering. Biofabrication 2013;5.
35. Yun HS, Kim SE, Park EK. Bioactive glass-poly (epsilon-caprolactone) composite scaffolds with 3 dimensionally hierarchical pore networks. Mater Sci Eng C Mater 2011;31:198-205.
36. Wu CT, Luo YX, Cuniberti G, Xiao Y, Gelinsky M. Three-dimensional printing of hierarchical and tough mesoporous bioactive glass scaffolds with a controllable pore architecture, excellent mechanical strength and mineralization ability. Acta Biomater 2011;7:2644-50.
37. Radu DR, Lai CY, Jeftinija K, Rowe EW, Jeftinija S, Lin VSY. A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. J Am Chem Soc 2004;126:13216-7.
38. Yan XX, Yu CZ, Zhou XF, Tang JW, Zhao DY. Highly ordered mesoporous bioactive glasses with superior in vitro bone-forming bioactivities. Angew Chem Int Ed 2004;43:5980-4.
39. Matsubara T, Suardita K, Ishii M, Sugiyama M, Igarashi A, Oda R, et al. Alveolar bone marrow as a cell source for regenerative medicine: differences between alveolar andiliacbone marrowstromalcells.JBoneMinerRes 2005;20:399-409.
40. Gao CX, Rahaman MN, Gao Q, Teramoto A, Abe K. Robotic deposition and in vitro characterization of 3D gelatinbioactive glass hybrid scaffolds for biomedical applications. J Biomed Mater Res A 2013;101:2027-37.
41. Bemer-Melchior P, Bryskier A, Drugeon HB. Comparison of the in vitro activities of rifapentine and rifampicin against mycobacterium tuberculosis complex. J Antimicrob Chemother 2000;46:571-5.
42. Rastogi N, Labrousse V, Goh KS. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. Curr Microbiol 1996;33:167-75.
43. Zhang JH, Zhao SC, Zhu YF, Huang YJ, Zhu M, Tao CL, et al. Three-dimensional printing of strontium-containing mesoporous bioactive glass scaffolds for bone regeneration. Acta Biomater 2014;10:2269-81.
44. Wu CT, Miron R, Sculean A, Kaskel S, Doert T, Schulze R, et al. Proliferation, differentiation and gene expression of osteoblasts in boron-containing associated with dexamethasone deliver from mesoporous bioactive glass scaffolds. Biomaterials 2011;32:7068-78.